Laurion Capital Management’s Audentes Therapeutics, Inc BOLD Stock Holding History

Laurion Capital Management’s Portfolio BOLD Stock Details BOLD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-9,844	Closed	-$589K	–	1235
2019 Q4	$589K	Sell	9,844 -12,256	-55%	-$460K	﹤0.01%	665
2019 Q3	$621K	Buy	22,100 +9,724	+79%	+$332K	﹤0.01%	730
2019 Q2	$469K	Buy	+12,376	New	+$475K	﹤0.01%	708
2017 Q4	–	Sell	-100,600	Closed	-$2.82M	–	1986
2017 Q3	$2.82M	Buy	+100,600	New	+$2.18M	0.01%	672
2016 Q4	–	Sell	-15,000	Closed	-$267K	–	1363
2016 Q3	$267K	Buy	+15,000	New	+$228K	﹤0.01%	742

Laurion Capital Management's BOLD Position: Q1 2020 in Review

Laurion Capital Management sold out of Audentes Therapeutics, Inc (BOLD) in Q1 2020, closing a stake of 9,844 shares — an estimated $589K sold.

Laurion Capital Management first reported a position in BOLD in Q3 2016 and held it in 5 quarters. The position peaked at $2.82M in Q3 2017. 0 funds tracked by Wall St. Rank hold BOLD as of Q1 2020.

Laurion Capital Management reported no remaining Audentes Therapeutics, Inc position as of Q1 2020 after selling out during the quarter.
Laurion Capital Management sold 9,844 Audentes Therapeutics, Inc shares in Q1 2020, an estimated $589K.
Laurion Capital Management first reported a position in Audentes Therapeutics, Inc in Q3 2016 and held it in 5 quarters.
Laurion Capital Management's Audentes Therapeutics, Inc position peaked at $2.82M in Q3 2017.
0 funds tracked by Wall St. Rank held Audentes Therapeutics, Inc as of Q1 2020.

Based on Laurion Capital Management's 13F filing for Q1 2020, filed 14 May 2020.